These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1911702)

  • 1. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase induce reductase accumulation and altered lamellar bodies in rat forestomach keratinocytes.
    Singer II; Kawka DW; Scott S; Bailey P; Kloss MW; Majka J; MacDonald JS
    Arterioscler Thromb; 1991; 11(5):1156-65. PubMed ID: 1911702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propionic acid and pravastatin on HMG-CoA reductase activity in relation to forestomach lesions in the rat.
    Bueld JE; Bannenberg G; Netter KJ
    Pharmacol Toxicol; 1996 Apr; 78(4):229-34. PubMed ID: 8861780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes.
    Singer II; Scott S; Kazazis DM; Huff JW
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5264-8. PubMed ID: 3293052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the rodent forestomach.
    Kloss MW; Patrick DH; MacDonald JS
    Food Chem Toxicol; 1991 Sep; 29(9):621-8. PubMed ID: 1937293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro.
    Kurakata S; Kada M; Shimada Y; Komai T; Nomoto K
    Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats.
    Yamauchi S; Linscheer WG; Beach DH
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G625-30. PubMed ID: 2018137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin treatment inhibits sterol synthesis and induces HMG-CoA reductase activity in mononuclear leukocytes of normal subjects.
    Stone BG; Evans CD; Prigge WF; Duane WC; Gebhard RL
    J Lipid Res; 1989 Dec; 30(12):1943-52. PubMed ID: 2621421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in the rat ileum: effects of bile acids and lovastatin.
    Nguyen LB; Shefer S; Salen G; Ness GC; Batta A; Chowdhary IR; Paroulek E; Hauser S
    Metabolism; 1994 Nov; 43(11):1446-50. PubMed ID: 7968602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin.
    Cheng H; Rogers JD; Sweany AE; Dobrinska MR; Stein EA; Tate AC; Amin RD; Quan H
    Pharm Res; 1992 Dec; 9(12):1629-33. PubMed ID: 1488408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HMG-CoA synthase and HMG-CoA reductase by insulin and epidermal growth factor in HaCaT keratinocytes.
    Harris IR; Höppner H; Siefken W; Farrell AM; Wittern KP
    J Invest Dermatol; 2000 Jan; 114(1):83-7. PubMed ID: 10620120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of 3-hydroxy-3-methylglutaryl CoA reductase and 3-hydroxy-3-methylglutaryl CoA synthase in the rat liver and intestine is affected by cholestyramine and mevinolin.
    Li AC; Tanaka RD; Callaway K; Fogelman AM; Edwards PA
    J Lipid Res; 1988 Jun; 29(6):781-96. PubMed ID: 2902179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term administration of HMG-CoA reductase inhibitors on cholesterol synthesis in lens.
    Kalinowski SS; Tanaka RD; Mosley ST
    Exp Eye Res; 1991 Aug; 53(2):179-86. PubMed ID: 1915674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase.
    Laufs U; Fata VL; Liao JK
    J Biol Chem; 1997 Dec; 272(50):31725-9. PubMed ID: 9395516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.